Fr. 40.50

Drugs for Life - How Pharmaceutical Companies Define Our Health

English · Paperback / Softback

Shipping usually within 3 to 5 weeks (title will be specially ordered)

Description

Read more

Informationen zum Autor Joseph Dumit is Director of Science and Technology Studies and Professor of Anthropology at the University of California, Davis. He is the author of Picturing Personhood: Brain Scans and Biomedical Identity and editor, with Regula Valérie Burri, of Biomedicine as Culture: Instrumental Practices, Technoscientific Knowledge, and New Modes of Life. Klappentext Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs. Zusammenfassung Joseph Dumit argues that underlying Americans' burgeoning consumption of prescription drugs and the skyrocketing cost of healthcare is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. Inhaltsverzeichnis Acknowledgments ix List of Illustrations xi Introduction 1 1. Responding to Facts 27 2. Pharmaceutical Witnessing and Direct-to-Consumer Advertising 55 3. Having to Grow Medicine 87 4. Mass Health: Illness Is a Line You Cross 105 5. Moving the Lines: Deciding on Thresholds 135 6. Knowing Your Numbers: Pharmaceutical Lifestyles 181 Conclusion. Living in a World of Surplus Health: Frequently Asked Questions 197 Notes 219 References 239 Index 257...

Product details

Authors Joseph Dumit
Publisher Duke University Press
 
Languages English
Product format Paperback / Softback
Released 03.09.2012
 
EAN 9780822348719
ISBN 978-0-8223-4871-9
No. of pages 277
Series Experimental Futures: Technolo
Experimental Futures
Experimental Futures: Technolo
Subjects Humanities, art, music > Education > Social education, social work
Natural sciences, medicine, IT, technology > Medicine > General
Social sciences, law, business > Business > Individual industrial sectors, branches

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.